UCB is a global biopharmaceutical company with a shared ambition to transform the lives of people living with severe diseases. With a focus on central nervous system and immunology disorders, UCB puts patients at the center of their world.
Reducing the risk of SUDEP: What GPs need to know
Part 1 of this 2-hour module contains information about SUDEP (sudden unexpected death in epilepsy) and strategies for discussing the risks of SUDEP with patients and their families. In part 2 you will be asked to use the SUDEP and Seizure Safety Checklist, to assess two people with epilepsy in your practice.
